BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Direct Healthcare Professional Communication (DHPC) on Cyclophosphamid beta 500 mg/ml, 1000 mg/2 ml, 2000 mg/4 ml concentrate for solution for injection/infusion (cyclophosphamide): Contraindicated in children and adolescents due to alcohol content

Active substance: cyclophosphamide

betapharm Arzneimittel GmbH in agreement with the Federal Institute for Drugs and Medical Devices (BfArM) would like to inform you that Cyclophosphamid beta 500 mg/ml, 1000 mg/2 ml, 2000 mg/4 ml concentrate for solution for injection/infusion are an alcoholic (ethanolic) solution of the medicinal product cyclophosphamide and are contraindicated in children and adolescents (i.e. under 18 years of age). The products should be used in adults only. Cyclophosphamid beta 500 mg/ml, 1000 mg/2 ml, 2000 mg/4 ml should not be used during pregnancy.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 120KB, File is accessible